androstane-3-17-diol-glucuronide and Hypertrichosis

androstane-3-17-diol-glucuronide has been researched along with Hypertrichosis* in 3 studies

Reviews

1 review(s) available for androstane-3-17-diol-glucuronide and Hypertrichosis

ArticleYear
[Androstanediol, androstanediol glucuronide].
    Nihon rinsho. Japanese journal of clinical medicine, 2005, Volume: 63 Suppl 8

    Topics: Acne Vulgaris; Androgen-Insensitivity Syndrome; Androstane-3,17-diol; Biomarkers; Diagnostic Techniques, Endocrine; Enzyme-Linked Immunosorbent Assay; Female; Gas Chromatography-Mass Spectrometry; Humans; Hypertrichosis; Male; Prostatic Hyperplasia; Radioimmunoassay; Reference Values; Specimen Handling

2005

Other Studies

2 other study(ies) available for androstane-3-17-diol-glucuronide and Hypertrichosis

ArticleYear
Clinical assessment and serum hormonal profile in prepubertal hypertrichosis.
    Hormone research, 2000, Volume: 54, Issue:1

    Twenty-two prepubertal girls with hypertrichosis were studied and compared to 10 prepubertal normal girls. Hypertrichosis was assessed according to a score that considers the amount and the distribution of vellus hair in androgen- and non-androgen-sensitive areas. Serum androgen profile and free androgen index (FAI) were determined in both groups. The hypertrichosis score was higher in patients than in the normal girls. Testosterone levels and FAI were increased in patients when compared to control; 3alpha-androstanediol glucuronide levels above 2 SD from the control mean were found in 10 girls and all hormonal parameters falling in the normal range were found in 4 girls. The new score designed to assess the degree of hypertrichosis was useful to differentiate between normal and pathological hair growth. Although most of the girls with prepubertal hypertrichosis showed an increased androgen bio-availability, a slight increase in peripheral 5alpha-reductase activity and a completely normal androgen profile was also associated with a pathological hair growth.

    Topics: Androgens; Androstane-3,17-diol; Androstenedione; Child; Child, Preschool; Dehydroepiandrosterone Sulfate; Diagnosis, Differential; Female; Humans; Hypertrichosis; Reference Values; Sex Hormone-Binding Globulin; Testosterone

2000
Bioactive and peripheral androgens in prepubertal simple hypertrichosis.
    Clinical endocrinology, 1990, Volume: 33, Issue:3

    Prepubertal simple hypertrichosis is characterized by excessive growth of vellus hair in children without other signs of endocrinopathies. The aetiology is unknown and it is not clear if it is an abnormal entity or an extreme form of the normal range of hair growth. Sixteen girls (aged 7 +/- 1.9 years, mean +/- SD) with prepubertal simple hypertrichosis and, as controls, 12 normal age-matched girls were studied. All patients were in preadrenarchal age and in all patients an ACTH test was performed to exclude non-classical forms of congenital adrenal hyperplasia. Testosterone (T), androstenedione (A), dehydroepiandrosterone sulphate (DHA-S), dihydrotesterone (DHT), 3 alpha-androstanediol (3Ad) and its glucuronide (3AG), and sex hormone binding globulin (SHBG) were evaluated and free testosterone (FT) and T/SHBG ratio were calculated in all subjects. In all patients we found T, A and DHA-S plasma levels comparable to controls, excluding an increased glandular androgen secretion. No significant differences, compared to controls, were observed for SHBG, FT and T/SHBG ratio, suggesting a normal T bioavailability. DHT plasma levels were significantly increased with respect to controls (0.42 +/- 0.04 vs 0.11 +/- 0.03 nmol/l; P less than 0.002) whereas 3Ad and 3AG were comparable to controls. The very significant increase in DHT plasma levels, without a parallel increase in 3Ad and 3AG found in our cases with prepubertal simple hypertrichosis, is difficult to explain. The clinical and biochemical significance of the high DHT plasma values needs more investigation.

    Topics: Androgens; Androstane-3,17-diol; Androstenedione; Child; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Dihydrotestosterone; Female; Humans; Hypertrichosis; Puberty; Sex Hormone-Binding Globulin; Testosterone

1990